Marks Group Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Marks Group Wealth Management's PFE Position: Q4 2023 in Review
Marks Group Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 72,182 shares — an estimated $2.39M sold.
Marks Group Wealth Management first reported a position in PFE in Q4 2019 and held it in 16 quarters. The position peaked at $2.39M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Marks Group Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Marks Group Wealth Management sold 72,182 Pfizer shares in Q4 2023, an estimated $2.39M.
- Marks Group Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 16 quarters.
- Marks Group Wealth Management's Pfizer position peaked at $2.39M in Q3 2023.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Marks Group Wealth Management's 13F filing for Q4 2023, filed 1 Feb 2024.